Identified HLA class I epitopes can undergo conformational induced variation due to changes within HLA bound peptides

Immunology Letters

Volumn 161, Issue 1, 2014, Pages 57-58

  Battle, R ^a   Turner, D ^a   Woodroofe, N ^b   Clark, B ^c  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c St James University   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIBODY; HLA ANTIGEN CLASS 1; PEPTIDE; PROTEIN BINDING;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN DETECTION; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CROSS REACTION; HUMAN; HYDROGEN BOND; LETTER; MOLECULAR DYNAMICS; PREDICTION; PRIORITY JOURNAL; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION;

EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 84901058346     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.04.016     Document Type: Letter

References (10)

1. Bagnasco S.M., Zachary A.A., Racusen L.C., Arend L.J., Carter-Monroe N., Alachkar N., et al. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation 2013, [Epub ahead of print].
2. Wiebe C., Pochinco D., Blydt-Hansen T.D., Ho J., Birk P.E., Karpinski M., et al. Class II epitope matching - a strategy to minimise de-novo donor-specific antibody development and improve outcomes. Am J Transplant 2013, 13:3114-3122.
3. Patel R., Terasaki P.I. The significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969, 280:735-739.
4. Duquesnoy R.J., Marrari M. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies. Curr Opin Organ transpl 2009, 14:403-409.
5. El-Awar N.R., Akaza T., Terasaki P.I., Nquyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007, 84:532-540.
6. Kosmoliaptsis V., Dafforn T.R., Chaudhry A.N., Halsall D.J., Bradley A.J., Taylor C.J. High resolution-three dimensional modelling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol 2011, 72:1049-1059.
7. Duquesnoy R.J., Marrai M., Jelenik L., Zeevi A., Class F.H.J., Mulder A. Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays. Hum Immunol 2013, 74:1271-1279.
8. Hülsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G., Coulie P.G., et al. A major histocompatibility complex peptide-restricted antibody and T cell receptor molecules recognise their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1 MAGE-A1 in complex with FAB-HYB3. J Biol Chem 2004, 280:2972-2980.
9. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The protein databank. Nucleic Acids Res 2000, 28:235-242.
10. Guex N., Peitsch M.C. SWISS-MODEL and Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.